mk2 Biotechnologies was selected as one of Germany's and Swiss' regional finalist at the European Health Catapult by EIT Health in the BioTech start-ups category. We are looking forward to our pitch and fruitful discussions in Heidelberg on July 11th 2018 next to 12 other great start-ups and finalists. Come [...]
Being selected as one of the finalist for the Achema Gründerpreis, mk2 Biotechnologies attended this year’s Achema World Forum in Frankfurt and presented at a booth and in an oral presentation the advantages of its superior peptide synthesis technology. In several discussions with experts and enthusiasts mk2 Biotechnologies underlined its [...]
mk2 Biotechnologies participated as emerging startup at the BioVaria 2018 in Munich, Germany. The oral and poster presentations catalyzed fruitful discussions with technology experts from industry and finance underlining the importance of new peptide synthesis technologies.